"The study adds to growing evidence that dupilumab, while highly effective for managing atopic dermatitis, may also be linked ...

CSPC Pharmaceutical Group ( ($HK:1093) ) has issued an update. CSPC Pharmaceutical Group has announced that its Dupilumab Injection, a biosimilar ...

For nearly a decade, 71-year-old Ho Thian Kong struggled with the effects of chronic rhinosinusitis with nasal polyps, a ...

For severe chronic rhinosinusitis with nasal polyps, the novel monoclonal antibody stapokibart reduced symptoms and polyp size atop treatment with a daily intranasal corticosteroid. The polyp size ...